286 related articles for article (PubMed ID: 16354890)
1. A trial of contraceptive methods in women with systemic lupus erythematosus.
Sánchez-Guerrero J; Uribe AG; Jiménez-Santana L; Mestanza-Peralta M; Lara-Reyes P; Seuc AH; Cravioto MD
N Engl J Med; 2005 Dec; 353(24):2539-49. PubMed ID: 16354890
[TBL] [Abstract][Full Text] [Related]
2. Menopause hormonal therapy in women with systemic lupus erythematosus.
Sánchez-Guerrero J; González-Pérez M; Durand-Carbajal M; Lara-Reyes P; Jiménez-Santana L; Romero-Díaz J; Cravioto MD
Arthritis Rheum; 2007 Sep; 56(9):3070-9. PubMed ID: 17763408
[TBL] [Abstract][Full Text] [Related]
3. Combined oral contraceptives in women with systemic lupus erythematosus.
Petri M; Kim MY; Kalunian KC; Grossman J; Hahn BH; Sammaritano LR; Lockshin M; Merrill JT; Belmont HM; Askanase AD; McCune WJ; Hearth-Holmes M; Dooley MA; Von Feldt J; Friedman A; Tan M; Davis J; Cronin M; Diamond B; Mackay M; Sigler L; Fillius M; Rupel A; Licciardi F; Buyon JP;
N Engl J Med; 2005 Dec; 353(24):2550-8. PubMed ID: 16354891
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
Chang DM; Lan JL; Lin HY; Luo SF
Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
[TBL] [Abstract][Full Text] [Related]
5. Flares in pediatric systemic lupus erythematosus.
Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
[TBL] [Abstract][Full Text] [Related]
6. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study.
Mok CC; To CH; Mak A; Ma KM
Arthritis Rheum; 2005 Dec; 52(12):3997-4002. PubMed ID: 16320346
[TBL] [Abstract][Full Text] [Related]
8. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
Brunner HI; Silverman ED; Bombardier C; Feldman BM
Arthritis Rheum; 2003 Jun; 49(3):335-41. PubMed ID: 12794788
[TBL] [Abstract][Full Text] [Related]
9. Accurately describing changes in disease activity in Systemic Lupus Erythematosus.
Gladman DD; Urowitz MB; Kagal A; Hallett D
J Rheumatol; 2000 Feb; 27(2):377-9. PubMed ID: 10685800
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
11. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.
Gordon C; Wallace DJ; Shinada S; Kalunian KC; Forbess L; Braunstein GD; Weisman MH
Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794
[TBL] [Abstract][Full Text] [Related]
12. Reversible contraception for the woman over 35 years of age.
Archer DF
Curr Opin Obstet Gynecol; 1992 Dec; 4(6):891-6. PubMed ID: 1450355
[TBL] [Abstract][Full Text] [Related]
13. Ovarian failure and flares of systemic lupus erythematosus.
Mok CC; Wong RW; Lau CS
Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
[TBL] [Abstract][Full Text] [Related]
14. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial.
Mok CC; Ying SK; Ma KM; Wong CK
Lupus; 2013 Dec; 22(14):1470-8. PubMed ID: 24113197
[TBL] [Abstract][Full Text] [Related]
15. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
Vieira CS; Pereira FV; de Sá MF; Paulo LJ; Martins WP; Ferriani RA
Maturitas; 2009 Mar; 62(3):311-6. PubMed ID: 19193505
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive therapy and systemic lupus erythematosus.
Travers RL; Hughes GR
J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives in women with systemic lupus erythematosus.
Buyon JP
Ann Med Interne (Paris); 1996; 147(4):259-64. PubMed ID: 8952745
[TBL] [Abstract][Full Text] [Related]
18. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
19. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
Petri MA; Lahita RG; Van Vollenhoven RF; Merrill JT; Schiff M; Ginzler EM; Strand V; Kunz A; Gorelick KJ; Schwartz KE;
Arthritis Rheum; 2002 Jul; 46(7):1820-9. PubMed ID: 12124866
[TBL] [Abstract][Full Text] [Related]
20. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
